Another meta-analysis reported that PD-L1 expressed on immune cells was associated with good prognosis, while PD-L1 expression on tumor cells has heterogeneous outcomes and does not meet requirements of a prognostic marker due to absence of standardization [90]. This evidence concerns the gene CD274 and neoplasm.